Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

NexBio Reports Positive Data from Test of Biologic Flu Drug

publication date: Aug 30, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
NexBio, a San Diego biotech startup, has released positive data from a Phase II trial of a novel biologic that aims to both treat and prevent infection by all flu strains. The drug works by inhibiting entry of the virus into cells. NexBio was formed by a China husband-wife team who did their early academic work in China, and then moved to the US to earn biology PhDs. NexBio has been in the news recently because the FBI conducted a very public raid on the company’s offices, though neither the FBI nor the company has explained the object of the raid. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...